| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.494 | 23.079 | 32.656 | 26.863 | 22.161 | 27.490 | 11.206 | 41.909 | 40.657 | 35.041 |
| Total Income - EUR | 22.494 | 23.079 | 32.656 | 26.863 | 22.161 | 27.490 | 11.206 | 41.909 | 40.657 | 38.008 |
| Total Expenses - EUR | 18.271 | 21.163 | 18.318 | 14.029 | 8.526 | 8.736 | 2.611 | 20.641 | 13.326 | 14.041 |
| Gross Profit/Loss - EUR | 4.223 | 1.916 | 14.338 | 12.834 | 13.634 | 18.754 | 8.595 | 21.268 | 27.331 | 23.968 |
| Net Profit/Loss - EUR | 3.139 | 1.498 | 13.358 | 12.028 | 12.954 | 17.924 | 8.428 | 20.874 | 26.933 | 23.595 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biosantosana Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 758 | 617 | 355 | 361 | 0 | 0 | 0 | 0 | 992 | 0 |
| Current Assets | 5.406 | 10.091 | 18.872 | 29.897 | 26.921 | 33.237 | 25.361 | 45.167 | 27.557 | 24.690 |
| Inventories | 373 | 1.673 | 69 | 131 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.535 | 7.405 | 16.897 | 22.817 | 21.104 | 17.718 | 22.282 | 26.842 | 21.077 | 21.209 |
| Cash | 498 | 1.013 | 1.907 | 6.950 | 5.817 | 15.519 | 3.079 | 18.326 | 6.480 | 3.481 |
| Shareholders Funds | 2.120 | 3.583 | 16.702 | 28.406 | 24.804 | 30.640 | 24.035 | 44.837 | 26.981 | 23.643 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 40 |
| Debts | 4.043 | 7.125 | 2.526 | 1.851 | 2.131 | 2.611 | 1.326 | 331 | 1.583 | 1.047 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8210 - 8210" | |||||||||
| CAEN Financial Year |
8219
|
|||||||||
Comments - Biosantosana Srl